Business Wire

SEOUL-SEMICONDUCTOR

Share
Seoul Semiconductor Continuously Pursues patent infringement actions against Everlight products

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890) — On April 28, 2017, Seoul Semiconductor Europe GmbH (“Seoul”) filed a patent infringement claim in Germany at the District Court of Düsseldorf against Mouser Electronic Inc. (“Mouser), a global electronic components distributor, which it accused of selling Everlight LED products.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170524005266/en/

In its complaint, Seoul asserted that Everlight’s Mid-Power LED products are infringing Seoul’s patent rights. Seoul has sought a permanent injunction, damages, and recall and destruction of the allegedly infringing products.

The asserted patent serves to improve the light extraction performance of LED devices by enhancing internal-reflection efficiency, which has been widely used in mid-power and high-power LEDs.

This patent litigation is the second patent infringement litigation by Seoul or its affiliate affecting Everlight’s LED products. In March 2017, Seoul Semiconductor Co., Ltd. filed a patent infringement claim in Germany, accusing high-power LED products manufactured by Everlight as well as other LED manufacturers. These patent litigations underscore Seoul’s commitment to protecting its intellectual property rights against infringement, including products consisting of mid-power LEDs and high-power LEDs.

In addition to Seoul’s patent infringement actions, Everlight has been implicated in other patent infringement lawsuits as described below. Nam Ki-bum, Vice President of the Research Center at Seoul, said, “Several LED companies have grown rapidly in a short period of time despite a lack of valuable patent portfolios, which is like building a castle on quicksand. There is no underlying foundation for the company’s products. Seoul, however, has been investing 10% of its revenue in research and development for many years to develop innovative technology and strengthen our patent portfolio. To support a fair market that respects intellectual property rights, Seoul will continuously monitor and take action against alleged infringers in any countries where infringement occurs.”

* Reference [source: various media news articles]

Plaintiff   Defendant   Business Relation   Patented Technology   Courts   State   Link
Nichia   WOFI Leuchten   Everlight subsidiary   phosphor   Düsseldorf District Court, Germany   Nichia won the suit in the court of first instance and the court ruled for an injunction  

http://www.ledinside.com/news/2016/12
/nichia_clinches_two_legal_victories_ag
ainst_everlight_in_german_district_court
s

http://www.nichia.co.jp/en/about_nichia/2
016/2016_122102.html

Nichia   REGO-Lighting   Used a white LED tube light product by Everlight subsidiary Zenar   phosphor   Düsseldorf District Court, Germany   On Dec. 5, 2016, the appeals court confirmed patent infringement and ruled in favor of Nichia.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_122101.html

http://www.ledinside.com/news/2016/12/
nichia_clinches_two_legal_victories_aga
inst_everlight_in_german_district_courts

Nichia   Everlight   Everlight   phosphor   Düsseldorf District Court, Germany   On Oct. 24, 2016, the court granted a preliminary injunction.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_111701.html

http://www.ledinside.com/news/2016/11/
german_court_grants_nichia_preliminary
_injunctions_for_white_led_products_that
_infringed_patents

Nichia   Tachibana Eletech and E&E Japan   Distributor of blue LEDs manufactured by Everlight in Japan   LED chip   Tokyo District Court, Japan   On Oct. 14, 2016, the court issued an oder ruled for an infringement in favor of Nichia.  

http://www.nichia.co.jp/en/about_nichia/2016
/2016_102001.html

http://www.ledinside.com/press/2016/10/nich
ia_wins_patent_infringement_lawsuit_agains
t_tachibana_and_ee_japan_in_tokyo

Nichia   Mouser   Distributor of Everlight products   phosphor   Düsseldorf District Court, Germany   On Oct. 7, 2016, the court granted a preliminary injunction.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_101301.html

http://www.ledinside.com/news/2016/10/g
erman_court_grants_preliminary_injunctio
n_against_mouser_based_on_nichia_yag
_patent

Nichia   Everlight   Everlight   LED Package   The U.S. District Court for the Eastern District of Texas   The Federal Circuit affirmed an infringement of Nichia’s patents.  

http://www.nichia.co.jp/en/about_nichia/20
17/2017_050901.html

http://www.ledinside.com/news/2017/5/nic
hia_wins_important_victory_in_federal_ci
rcuit_appeal

Nichia   EBV Elektronik GmbH & Co. KG and EBV Management GmbH (both “EBV“)   Distributor of Everlight products   phosphor   Düsseldorf District Court, Germany   Still in progress  

http://www.nichia.co.jp/en/about_nichia
/2017/2017_030802.html

http://www.ledinside.com/press/2017/3/nichia

_files_patent_infringement_lawsuit_against_

ebv_in_germany_regarding_white_led_

product_of_everlight

Nichia   Everlight Electronics (China) and Beijing Ducheng Yiguang Electronic Devices Selling Center   Everlight subsidiary   phosphor   Beijing Intellectual Property Court, China   Still in progress  

http://www.nichia.co.jp/en/about_nichia
/2016/2016_032401.html

http://www.ledinside.com/news/2016/3/
nichia_files_new_led_patent_infringem
ent_lawsuits_respectively_in_china_an
d_us

Seoul Semiconductor   Mouser   Distributor of Everlight products   High Power LED   Düsseldorf District Court, Germany   Still in progress  

http://www.ledinside.com/news/2017/4/se
oul_semiconductor_files_patent_infringe
ment_lawsuit_in_germany

Seoul Semiconductor   Mouser   Distributor of Everlight products   Mid Power LED   Düsseldorf District Court, Germany   On April 28, 2017, Seoul filed the lawsuit.    
           

About Seoul Semiconductor:

Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fifth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as Wicop – a simpler structured Package-Free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; Acrich, the world's leading direct AC LED; Acrich MJT multi-junction technology; a proprietary family of high-voltage LEDs; NanoDriver Series – World’s Smallest 24W DC LED Drivers and nPola, a new LED product based on GaN-substrate technology that achieves over ten times the output of conventional LEDs.

For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com

# Trademarks: Wicop and Acrich are trademarks of Seoul Semiconductor Co., Ltd.

Contact:

Asia
Seoul Semiconductor Co., Ltd
Jake Jung, +82 070.4391.8270
Email: pr@seoulsemicon.com
or
Europe
Seoul Semiconductor Europe GmbH
Ariane Heim, +49 (0)89 450 3690-0
Email: press.eu@seoulsemicon.com
or
North America
Seoul Semiconductor Inc.
David Cox, +1 (919) 410-9856
Email: David.cox@seoulsemicon.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Zetagen Therapeutics to Present Preliminary Results from Phase 2 Clinical Trial Targeting Metastatic Breast Cancer to Bone at the 2025 San Antonio Breast Cancer Symposium4.11.2025 16:04:00 CET | Press release

Complete Response in all treated lesions: Patients completing the study showed CR via the MD Anderson Criteria and RECIST v1.1 with no active tumor detected on MRIFirst-of-its-kind single intratumoral injection for MBC to the spineTreated lesions showed full bone regeneration with reconstitution of trabecular bone, and no skeletal related events; mean lesion defect volume decreased by 87.9% at day 180.Therapeutic spread extended to nearby non-treated lesions, also achieving complete response within the same vertebral body Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its abstract titled “Single Intratumoral Drug Injection Yields Complete Response (CR) in Metastatic Breast Cancer (MBC) Bone Lesions”, has been accepted and will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) on Wednesday, December 10, 2025. The abstract

ID5 Acquires TrueData, Combining Strengths to Create the Most Comprehensive Identity Solution for Digital Advertising4.11.2025 16:00:00 CET | Press release

Acquisition creates a global privacy-focused identity powerhouse and enhances value for partners through expanded capabilities ID5, the market-leading ID provider for digital advertising, has today announced the acquisition of TrueData, a top-tier US-based identity graph company. The deal represents a major step forward in ID5’s growth strategy, significantly strengthening its presence in the US and broadening the value it can deliver to partners worldwide. ID5, recognized as a global leader in the alternative ID space, has built a strong foothold in the US, where the majority of its clients and revenue originate. By bringing in TrueData’s graph, the company is expanding its operations in the US and strengthening its Adaptive Identity technology with new datasets and expertise. The combination of TrueData’s graph and expertise with the GDPR compliant ID5 Graph, and its scaled alternative ID creates a unique proposition in the market, connecting offline data with the largest online reac

Westlake Announces Proposed Offering of Senior Notes4.11.2025 15:15:00 CET | Press release

Westlake Corporation (NYSE: WLK) (“Westlake”) announced today the commencement of an underwritten public offering, subject to market and other conditions, of senior unsecured notes (the “Notes”) under its existing shelf registration statement. The timing of pricing and terms of the Notes are subject to market conditions and other factors. Westlake intends to use the net proceeds from the proposed public offering of the Notes to fund the repurchase of its outstanding 3.600% Senior Notes due 2026 (the “2026 Senior Notes”) pursuant to a concurrent cash tender offer (the “Tender Offer”) for any and all of the 2026 Senior Notes. Westlake anticipates using any remaining net proceeds to fund the purchase price of its pending acquisition of the global compounding solutions businesses of the ACI/Perplastic Group (the “ACI Acquisition”) and for general corporate purposes, including working capital management. The offering of the Notes is not contingent upon the successful completion of the Tende

Westlake Announces Cash Tender Offer4.11.2025 15:13:00 CET | Press release

Westlake Corporation (NYSE: WLK) (“Westlake”) announced today the commencement of a cash tender offer to purchase (the “Offer”) any and all of the outstanding 3.600% Senior Notes due 2026 (the “Notes”) as set forth in the table below. The tender offer is being made solely pursuant to the terms and conditions set forth in an Offer to Purchase, dated November 4, 2025 (the “Offer to Purchase”). Holders of the Notes are urged to carefully read the Offer to Purchase before making any decision with respect to the tender offer. The tender offer is not conditioned on any minimum amount of the Notes being tendered. Subject to applicable law, Westlake may amend, extend or terminate the tender offer in its sole discretion. Capitalized terms used but not defined in this announcement have the meanings given to them in the Offer to Purchase. Series of Notes CUSIP Numbers(1) Aggregate Principal Amount Outstanding U.S. Treasury Reference Security(2) Bloomberg Reference Page(2) Fixed Spread(3) 3.600% S

In-House Counsel Warn of Mounting Risks as Service of Process Volume Surges4.11.2025 15:00:00 CET | Press release

93% of in-house counsel say mass arbitration is increasing SOP risk and complexity59% report varying state requirements are driving compliance errors97% use AI for managing or analyzing SOP, yet 96% remain concerned about accuracy and speed The volume of service of process (SOP)—the legal procedure by which one party formally notifies another of a legal action—is surging across the U.S., amplifying operational pressure and compliance risk for in-house legal teams. This is according to a new nationwide study commissioned by CSC, industry-leading registered agent and compliance service provider. CSC surveyed 250 senior in-house counsel across the U.S. and found that rising SOP volume and growing concerns around data accuracy are intensifying both risk and workload pressure.1 Respondents cited data accuracy as a significant challenge to SOP management (61%), followed by rising SOP volume (56%). More than three-quarters (76%) said their departments are spending “too much” or “excessive” ti

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye